ICU Medical, Inc. april 24, 2025 Please complete the form below to contact Kaplan Fox regarding the ICU Medical Investigation: Join a Case First Name * Last Name * Email Address * Phone Number * Ticker Symbol Or Company Name * Please Insert Your Estimation Of Losses In USD * Are you a current or former employee of the company mentioned having traded above? * Yes No Captcha Submit If you are human, leave this field blank. Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an ICU Medical investor and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. On April 22, 2025, Bloomberg reported that the Federal Drug Administration (“FDA”) had issued a Warning Letter to ICU Medical “regarding unapproved changes to its infusion pumps.” The Warning Letter, dated April 4, 2025, which was based on an FDA inspection from July 23 through August 9, 2024, states that the Company “made multiple changes to the Medfusion® Model 4000 Syringe Infusion Pump and CADD® Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices,” and that the Company “failed to submit a premarket notification submission to [the] FDA for significant changes or modifications that could significantly affect the safety or effectiveness of these devices. . . .” The Warning Letter further states that the pumps are “adulterated . . . because [the Company] does not . . . have an approved application for premarket approval (PMA) in effect.” Following this news, the price of ICU Medical stock declined by as much as $10.72 per share, or by approximately 8%, during intraday trading. On April 22, 2025, ICU shares closed at $130.68 per share, a decline of $6.04 per share, or over 4%, from the closing price the prior day. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this investigation, please contact: CONTACT: Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. Any information you submit will be maintained as confidential. If Kaplan Fox, in its sole discretion, believes that you might be an appropriate client, Kaplan Fox will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases. Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us ICU Medical, Inc. See the Case Ibotta, Inc. See the Case Aldeyra Therapeutics, Inc. See the Case Franklin Resources, Inc. See the Case Open Lending Corporation See the Case The Bancorp, Inc. See the Case The Vita Coco Company, Inc. See the Case BigBear.ai Holdings See the Case Viatris Inc. See the Case Zynex Inc. See the Case Hesai Group See the Case Ready Capital Corporation See the Case
